Highland Capital Management (Texas)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Highland Capital Management (Texas)’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-300,000	Closed	-$5.44M	–	359
2016 Q3	$5.44M	Buy	+300,000	New	+$5.86M	0.17%	114
2016 Q1	–	Sell	-728,807	Closed	-$15.8M	–	294
2015 Q4	$15.8M	Buy	728,807 +378,473	+108%	+$7.37M	0.5%	59
2015 Q3	$6.95M	Buy	+350,334	New	+$11.1M	0.2%	123

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highland Capital Management (Texas)'s HZNP Position: Q4 2016 in Review

Highland Capital Management (Texas) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2016, closing a stake of 300,000 shares — an estimated $5.44M sold.

Highland Capital Management (Texas) first reported a position in HZNP in Q3 2015 and held it in 3 quarters. The position peaked at $15.8M in Q4 2015. 234 funds tracked by Wall St. Rank hold HZNP as of Q4 2016.

Highland Capital Management (Texas) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2016 after selling out during the quarter.
Highland Capital Management (Texas) sold 300,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2016, an estimated $5.44M.
Highland Capital Management (Texas) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 3 quarters.
Highland Capital Management (Texas)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15.8M in Q4 2015.
234 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2016, filed 13 Feb 2017.